FNCHQ
Price:
$10.35
Market Cap:
$16.62M
Finch Therapeutics Group, Inc. engages in the development of microbiome drugs. Its platform includes Human-First Discovery that enables reverse translation from clinical data to engineer the composition of the microbiome based on disease-modifying mechanisms. The company was founded by Mark Smith, Andrew Noh, Tom Borody and Zain Kassam in 2014 and is headquartered in Boston, MA.
Industry
Biotechnology
IPO Date
2021-03-18
Stock Exchange
OTC
Ticker
FNCHQ
According to Finch Therapeutics Group, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.
The mean historical Dividend Yield of Finch Therapeutics Group, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), FNCHQ's Dividend Yield was at its highest in in the March 2020 quarter at 0%. The Dividend Yield was at its lowest in in the March 2020 quarter at 0%.
Average
0%
Median
0%
Minimum
0%
Maximum
0%
Discovering the peaks and valleys of Finch Therapeutics Group, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual Dividend Yield = 0%
Minimum Annual Increase = 0%
Minimum Annual Dividend Yield = 0%
| Year | Dividend Yield | Change |
|---|---|---|
| 2024 | 0% | 0% |
| 2023 | 0% | 0% |
| 2022 | 0% | 0% |
| 2021 | 0% | 0% |
| 2020 | 0% | 0% |
The current Dividend Yield of Finch Therapeutics Group, Inc. (FNCHQ) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
0%
5-year avg
0%
10-year avg
0%
Finch Therapeutics Group, Inc.’s Dividend Yield is less than Biomea Fusion, Inc. (0%), less than Connect Biopharma Holdings Limited (0%), less than Edgewise Therapeutics, Inc. (0%), less than Werewolf Therapeutics, Inc. (0%), less than ImageneBio Inc (0%), less than Pasithea Therapeutics Corp. (0%), less than Quoin Pharmaceuticals, Ltd. (0%),
| Company | Dividend Yield | Market cap |
|---|---|---|
| 0% | $129.42M | |
| 0% | $81.22M | |
| 0% | $5.05B | |
| 0% | $46.80M | |
| 0% | $56.62M | |
| 0% | $16.93M | |
| 0% | $14.08M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Finch Therapeutics Group, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Finch Therapeutics Group, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the Dividend Yield?
How can you use the Dividend Yield?
What is Finch Therapeutics Group, Inc.'s Dividend Yield?
How is the Dividend Yield calculated for Finch Therapeutics Group, Inc. (FNCHQ)?
What is the highest Dividend Yield for Finch Therapeutics Group, Inc. (FNCHQ)?
What is the 3-year average Dividend Yield for Finch Therapeutics Group, Inc. (FNCHQ)?
What is the 5-year average Dividend Yield for Finch Therapeutics Group, Inc. (FNCHQ)?
How does the current Dividend Yield for Finch Therapeutics Group, Inc. (FNCHQ) compare to its historical average?